Literature DB >> 18342773

MDCT of the myocardium: a new contribution to ischemic heart disease.

Alexis Jacquier1, Didier Revel, Maythem Saeed.   

Abstract

RATIONALE AND
OBJECTIVES: Despite the progress made in diagnosis and treatment, cardiovascular diseases remain the main cause of death worldwide.
MATERIALS AND METHODS: Multidetector row computed tomography (MDCT) provides several diagnostic insights, namely assessment of coronary artery anatomy and measurement of left ventricular volume and function. The ability of CT to show myocardial infarcted areas as an enhanced territory was described in the late 1970s in an animal model.
RESULTS: This method found a second wind with the arrival of MDCT technology that led to its clinical application. Several authors describe the ability of MDCT to assess myocardial injury both in animals and humans. The MDCT assessment of myocardial late enhancement is based on the same principle as delayed enhancement MRI.
CONCLUSIONS: The aim of this review is to cover the technical aspects of cardiac MDCT in assessing the myocardium and its potential in diagnosing ischemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342773     DOI: 10.1016/j.acra.2007.11.004

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  4 in total

1.  Left ventricular myocardium segmentation on delayed phase of multi-detector row computed tomography.

Authors:  I-Chen Tsai; Yu-Len Huang; Po-Ting Liu; Min-Chi Chen
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-04-19       Impact factor: 2.924

2.  Reperfusion injury components and manifestations determined by cardiovascular MR and MDCT imaging.

Authors:  Maythem Saeed; Steve Hetts; Mark Wilson
Journal:  World J Radiol       Date:  2010-01-28

3.  Myocardial delayed-enhancement CT: initial experience in children and young adults.

Authors:  Hyun Woo Goo
Journal:  Pediatr Radiol       Date:  2017-05-23

Review 4.  Integrated PET/CT in the assessment of etiology and viability in ischemic heart failure.

Authors:  Yuri Sheikine; Marcelo F Di Carli
Journal:  Curr Heart Fail Rep       Date:  2008-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.